Astrazeneca shares fall after FTSE giant’s forecast lift fails to inspire
In the first half of 2024, Astrazeneca reported an 18 per cent year-on-year increase in total revenue, reaching $2.6bn (£2bn).
Talktalk: The telecoms titan on the brink
In a defining few months, Talktalk needs to refinance nearly a billion pounds of debt, with bidders circling. Will it survive?
Revolut’s long wait for a banking licence finally comes to an end
After more than three years, Revolut’s wait for a banking licence is finally over after it received authorisation from the banking watchdog. Revolut said it would now enter the ‘mobilisation‘ st
Veterinary group CVS gears up for Australia expansion
Veterinary group CVS announced 10 per cent revenue growth but weaker sales amid soft demand and the effect of a cyber security attack, while it separately announced a shift in strategy to focus on gro
Lloyds Bank profit slides as interest rate boom slows
Lloyds Banking Group recorded a slide in profit in the first half of the year after a surge in costs and a slowdown in the amount of cash it was making on the back of interest rates. The group – whi
Virgin Wines returns to black as subscription sign ups soar
Virgin Wines has returned to profitability despite a "challenging" backdrop, with its wine subscription service helping to offset its increased running costs.